These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27915371)

  • 1. Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro.
    Wang HF; Ning F; Liu ZC; Wu L; Li ZQ; Qi YF; Zhang G; Wang HS; Cai SH; Du J
    Cancer Immunol Immunother; 2017 Mar; 66(3):355-366. PubMed ID: 27915371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo.
    Rosborough BR; Castellaneta A; Natarajan S; Thomson AW; Turnquist HR
    J Leukoc Biol; 2012 May; 91(5):701-9. PubMed ID: 22028329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intact immune system is required for the anticancer activities of histone deacetylase inhibitors.
    West AC; Mattarollo SR; Shortt J; Cluse LA; Christiansen AJ; Smyth MJ; Johnstone RW
    Cancer Res; 2013 Dec; 73(24):7265-76. PubMed ID: 24158093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors.
    Hashimoto A; Fukumoto T; Zhang R; Gabrilovich D
    Cancer Immunol Immunother; 2020 Sep; 69(9):1929-1936. PubMed ID: 32435850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
    Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
    J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist.
    Frew AJ; Lindemann RK; Martin BP; Clarke CJ; Sharkey J; Anthony DA; Banks KM; Haynes NM; Gangatirkar P; Stanley K; Bolden JE; Takeda K; Yagita H; Secrist JP; Smyth MJ; Johnstone RW
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11317-22. PubMed ID: 18685088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
    Sinha P; Ostrand-Rosenberg S
    Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
    Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
    Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol ameliorates Lewis lung carcinoma-bearing mice development, decreases granulocytic myeloid-derived suppressor cell accumulation and impairs its suppressive ability.
    Zhao Y; Shao Q; Zhu H; Xu H; Long W; Yu B; Zhou L; Xu H; Wu Y; Su Z
    Cancer Sci; 2018 Sep; 109(9):2677-2686. PubMed ID: 29959821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.
    Vincent J; Mignot G; Chalmin F; Ladoire S; Bruchard M; Chevriaux A; Martin F; Apetoh L; Rébé C; Ghiringhelli F
    Cancer Res; 2010 Apr; 70(8):3052-61. PubMed ID: 20388795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1α, 25 Dihydroxyvitamin D (1,25(OH)
    Fleet JC; Burcham GN; Calvert RD; Elzey BD; Ratliff TL
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105557. PubMed ID: 31783150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.
    Hegde VL; Singh UP; Nagarkatti PS; Nagarkatti M
    J Immunol; 2015 Jun; 194(11):5211-22. PubMed ID: 25917103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells.
    Travelli C; Consonni FM; Sangaletti S; Storto M; Morlacchi S; Grolla AA; Galli U; Tron GC; Portararo P; Rimassa L; Pressiani T; Mazzone M; Trovato R; Ugel S; Bronte V; Tripodo C; Colombo MP; Genazzani AA; Sica A
    Cancer Res; 2019 Apr; 79(8):1938-1951. PubMed ID: 30777853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
    Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
    J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
    Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
    PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified method for differentiation of myeloid-derived suppressor cells
    Zhou H; Xie Z; Morikawa N; Sakurai F; Mizuguchi H; Okuzaki D; Okada N; Tachibana M
    Biochem Biophys Rep; 2023 Mar; 33():101416. PubMed ID: 36605123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells.
    Huang W; Liu Y; Luz A; Berrong M; Meyer JN; Zou Y; Swann E; Sundaramoorthy P; Kang Y; Jauhari S; Lento W; Chao N; Racioppi L
    Front Immunol; 2021; 12():754083. PubMed ID: 34712241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.